A Cure for Multiple Sclerosis? Scientists Say Within Our Lifetime
WEBJun 12, 2024 · Today, clinical studies like those being conducted by the UCSF Weill Institute for Neurosciences, which Hauser directs, are investigating new ways to aggressively treat MS sooner with existing medications and new, more powerful versions.
MS Cure: Latest Research and Clinical Trials - Verywell Health
WEBDec 12, 2021 · There is no cure for multiple sclerosis (MS), but research is ongoing. Learn about the progress made in research and current MS treatments.
The Promising Results of Tolebrutinib for Secondary Progressive ...
WEB1 day ago · During ECTRIMS, Fox, a staff neurologist at the Mellen Center for Multiple Sclerosis at Cleveland Clinic, sat down with NeurologyLive ® to discuss how the previously reported findings of HERCULES could potentially impact current treatment options for SPMS. He also talked about what makes this new …
FDA approves new drug to treat multiple sclerosis | FDA
WEBOn March 28, the U.S. Food and Drug Administration approved Ocrevus (ocrelizumab) to treat adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple...
FDA Approves Briumvi to Treat Relapsing Multiple Sclerosis
WEBOn December 28, 2022, the U.S. Food and Drug Administration (FDA) approved Briumvi (ublituximab), a disease-modifying therapy (DMT) to treat relapsing forms of multiple sclerosis (RMS) in adults,...
FDA Approves First Biosimilar to Treat Multiple Sclerosis
WEBThe U.S. Food and Drug Administration today approved Tyruko (natalizumab-sztn), the first biosimilar to Tysabri (natalizumab) injection for the treatment of adults with relapsing forms of...
FDA OKs Phase 2 clinical trial of KYV-101 for progressive MS
WEBJan 5, 2024 · The U.S. Food and Drug Administration (FDA) has cleared a Phase 2 clinical trial to test Kyverna Therapeutics ‘ cell-based therapy candidate KYV-101 in people with treatment-resistant...
CAR-T therapy for multiple sclerosis enters US trials for ... - Nature
WEBFeb 22, 2024 · The first US trials of engineered cells to treat multiple sclerosis have started recruiting volunteers, raising hopes for a new therapeutic option for this devastating neurodegenerative disease...
National MS Society updates Pathways to Cures Roadmap
WEBSep 11, 2024 · by Steve Bryson, PhD September 11, 2024. The National Multiple Sclerosis Society (NMSS) has updated its Pathways to Cures Roadmap to account for recent scientific advances in the search for a cure ...
Refined Pathways to Cures Roadmap Published in Multiple Sclerosis ...
WEB[September 3, 2024] – The Multiple Sclerosis Journal has published the next iteration of The Pathways to Cures Roadmap, which outlines research areas with the greatest potential to stop MS, restore function and repair damage from the disease, and end MS through prevention. The updated Roadmap accounts for recent scientific advances and provides recommendations which could accelerate progress ...